Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | enriched in the midbrain (1 nTPM), where the nigral dopamine neurons sit | 0.90 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 16611
Sealed predictions
- CSN3 in dopamine neurons, braak-0.14 (p 0.718) → +0.47 (p 0.197)receipt 16618
Swarm cases
receipt 16618: CSN3 in dopamine neurons, braak
- power
- full sample +0.15 (p 0.549, n 18), 95% CI -0.34 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.14 (p 0.591, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.25 (p 0.323, n 18). could be the mix.
- skeptic
- leave-one-out range +0.03 to +0.27, sign flips 0; without severely affected donors +0.15 (p 0.549, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CSN3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts